In the process of CRC, LINC00114 expression trends to up-regulate, and down-regulating LINC00114 inhibits proliferation in vitro, and retards tumor formation in vivo via reducing EZH2/DNA methyltransferase 1-induced methylation of miR-133b promoter [12]. Here, EZH2 is linked to neoplasm.